Let's Talk Risk! Podcast podcast

LTR 167: Making AI Work in MedTech QMS

0:00
27:21
Reculer de 15 secondes
Avancer de 15 secondes

Summary

“First you have to understand the technology, what the technology does, what it's capable of, and you have to understand its limitations.”

Artificial intelligence is rapidly changing how medical device companies operate. From complaint handling and nonconformance analysis to CAPA management and technical documentation, the opportunities for efficiency are substantial. But how do we ensure these new capabilities deliver reliable results without introducing unacceptable risks?

In this episode of the Let’s Talk Risk! conversation, host Naveen Agarwal speaks with Terry Irwin, Senior Distinguished Engineer at Edwards Lifesciences, about the practical realities of implementing AI within medical device quality management systems.

We explore why understanding AI’s capabilities and limitations must come before deployment, how risk-based decisions can guide validation and human oversight, and why quality professionals have an opportunity to lead this transformation.

Listen to the full 25-minute podcast or jump to a section of interest listed below.

Chapters

00:00 AI’s expanding role in MedTech quality

02:08 Understanding AI capabilities and limitations

06:04 Risk-based validation and implementation decisions

08:46 Complaint triage, nonconformance analysis, and CAPA

13:38 Building a risk-based decision framework

17:52 AI literacy, new skills, and opportunities

21:16 ChatGPT, Copilot, Gemini, and enterprise adoption strategies

25:51 Understanding AI and leading the future of MedTech quality

If you enjoyed this podcast, consider subscribing to the Let’s Talk Risk! newsletter.

Suggested links:

LTR: AI-Based Virtual Audits.

LTR: Building a MedTech Career in the Age of AI.

LTR: LTR Risk Coach - AI-Powered Decision Support Tool.

Key Takeaways

* Beyond the AI hype: Why organizations must understand what AI can—and cannot—reliably do before introducing it into regulated processes.

* AI in quality operations: Opportunities to improve complaint triage, nonconformance trending, CAPA analysis, and technical documentation.

* Risk-based validation: How a structured decision-tree approach can help determine when AI systems require validation, verification, or human review.

* The reliability challenge: Why evaluating AI performance requires understanding data completeness, output accuracy, and the consequences of incorrect decisions.

* Human oversight and accountability: The importance of reviewing AI-generated information, particularly when it becomes part of auditable quality records.

* A new leadership opportunity: Why AI literacy, software knowledge, and risk management expertise are becoming increasingly valuable skills for quality professionals.

Keywords

Artificial Intelligence, MedTech, Quality Management Systems, AI Validation, Risk-Based Decision Making, Human Oversight, Complaint Management, CAPA, AI Governance, Quality Leadership

About Terry Irwin

Terry Irwin is a Senior Distinguished Engineer at Edwards Lifesciences, with more than 25 years of experience in medical device quality, engineering, and regulatory compliance.

His career spans leadership and technical roles at Edwards Lifesciences, Nuvaira, Boston Scientific, and CIVCO Medical Solutions, with extensive experience in design controls, risk management, quality systems, software validation, and product development.

Terry currently serves in a quality leadership role supporting AI implementation, bringing together his background in software technology and medical device quality management to help guide responsible adoption.

Let’s Talk Risk! with Dr. Naveen Agarwal is a bi-weekly live audio event on LinkedIn, where we talk about risk management related topics in a casual, informal way. Join us at 11:00 am EST every other Friday on LinkedIn.

Disclaimer

Information and insights presented in this podcast are for educational purposes only, and not as legal advice. Views expressed by all speakers are their own and do not reflect those of their respective organizations.

Parts of this article were created using AI-generated content, which was subsequently reviewed, edited, and fact-checked by the author to ensure accuracy and alignment with our standards.



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit naveenagarwalphd.substack.com/subscribe

D'autres épisodes de "Let's Talk Risk! Podcast"